STOCK TITAN

[SCHEDULE 13G/A] GeoVax Labs, Inc. Warrants SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Armistice Capital, LLC and Steven Boyd report beneficial ownership of 2,675,610 shares of GeoVax Labs common stock, representing 9.54% of the class. Armistice Capital is the investment manager of the direct holder (the Master Fund) and reports shared voting and dispositive power over these shares. The Master Fund disclaims beneficial ownership to the extent it lacks voting or dispositive power under its agreement with Armistice Capital.

The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. Steven Boyd, as managing member of Armistice Capital, is reported as having the same shared voting and dispositive power.

Armistice Capital, LLC e Steven Boyd dichiarano la titolarità beneficiaria di 2.675.610 azioni ordinarie di GeoVax Labs, pari al 9,54% della categoria. Armistice Capital è il gestore degli investimenti del detentore diretto (il Master Fund) e segnala di detenere poteri condivisi di voto e disposizione su queste azioni. Il Master Fund rinuncia a rivendicare la titolarità beneficiaria nella misura in cui non dispone di poteri di voto o dispositivi in base all’accordo con Armistice Capital.

La comunicazione precisa che le azioni sono detenute nell’ordinario corso dell’attività e non sono state acquisite al fine di modificare o influenzare il controllo dell’emittente. Steven Boyd, in qualità di managing member di Armistice Capital, è indicato come titolare degli stessi poteri condivisi di voto e disposizione.

Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria de 2.675.610 acciones ordinarias de GeoVax Labs, lo que representa el 9,54% de la clase. Armistice Capital es el gestor de inversiones del titular directo (el Master Fund) y declara tener poderes compartidos de voto y disposición sobre estas acciones. El Master Fund renuncia a la propiedad beneficiaria en la medida en que carezca de poderes de voto o disposición conforme a su acuerdo con Armistice Capital.

El documento indica que las acciones se mantienen en el curso ordinario del negocio y no se adquirieron con el objetivo de cambiar o influir en el control del emisor. Steven Boyd, como managing member de Armistice Capital, figura con los mismos poderes compartidos de voto y disposición.

Armistice Capital, LLC와 Steven Boyd는 GeoVax Labs 보통주 2,675,610주(해당 클래스의 9.54%)에 대한 실질적 소유권을 신고했습니다. Armistice Capital은 직접 보유자(마스터 펀드)의 투자 운용사로서 이 주식들에 대해 공동 의결권 및 처분권을 보유하고 있다고 보고했습니다. 마스터 펀드는 Armistice Capital과의 계약에 따라 의결권이나 처분권이 없는 범위에 대해서는 실질적 소유권을 부인합니다.

신고서에는 해당 주식이 영업상의 통상적인 범위에서 보유되고 있으며 발행사의 통제권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아니라고 명시되어 있습니다. Armistice Capital의 매니징 멤버인 Steven Boyd도 동일한 공동 의결권 및 처분권을 보유한 것으로 보고되었습니다.

Armistice Capital, LLC et Steven Boyd déclarent la propriété bénéficiaire de 2 675 610 actions ordinaires de GeoVax Labs, représentant 9,54 % de la catégorie. Armistice Capital est le gestionnaire d’investissements du détenteur direct (le Master Fund) et déclare exercer des pouvoirs partagés de vote et de disposition sur ces actions. Le Master Fund décline la qualité de bénéficiaire dans la mesure où il ne dispose pas de pouvoirs de vote ou de disposition en vertu de son accord avec Armistice Capital.

Le dépôt précise que les actions sont détenues dans le cours normal des affaires et n’ont pas été acquises dans le but de modifier ou d’influencer le contrôle de l’émetteur. Steven Boyd, en tant que managing member d’Armistice Capital, est indiqué comme disposant des mêmes pouvoirs partagés de vote et de disposition.

Armistice Capital, LLC und Steven Boyd melden wirtschaftliches Eigentum an 2.675.610 Stammaktien von GeoVax Labs, was 9,54% der Klasse entspricht. Armistice Capital ist der Investmentmanager des direkten Inhabers (des Master Fund) und gibt an, über diese Aktien geteilte Stimm- und Verfügungsrechte zu besitzen. Der Master Fund weist wirtschaftliches Eigentum in dem Umfang zurück, in dem ihm gemäß der Vereinbarung mit Armistice Capital Stimm- oder Verfügungsrechte fehlen.

Die Meldung führt aus, dass die Aktien im normalen Geschäftsverlauf gehalten werden und nicht erworben wurden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Steven Boyd wird als Managing Member von Armistice Capital mit denselben geteilten Stimm- und Verfügungsrechten angegeben.

Positive
  • Material stake reported: Ownership of 2,675,610 shares equals a 9.54% position, signaling meaningful investor interest.
  • Clear governance disclosure: Armistice Capital discloses voting and dispositive authority via its role as investment manager.
Negative
  • None.

Insights

TL;DR: A hedge fund-affiliated manager reports a sizable 9.54% position with shared voting and dispositive power via a managed fund.

The position size—2,675,610 shares representing 9.54%—is material and must be monitored by investors for potential influence on governance or future actions. The filing clarifies that voting and disposition authority rests with Armistice Capital as investment manager of the Master Fund, while the Master Fund disclaims direct beneficial ownership to the extent it lacks such authority. The certification that the shares are held in the ordinary course of business and not for control limits, but does not eliminate, possible future coordination or activism.

TL;DR: Reporting shows shared voting/dispositive power through an investment manager, raising governance relevance for a sub-10% holder.

The reporting structure—Armistice Capital exercising voting and investment power on behalf of the Master Fund while the Master Fund disclaims beneficial ownership—highlights typical investment-management reporting mechanics. With nearly 10% ownership and shared voting power, the reporting persons could be influential in shareholder matters depending on other holders' dispersion. The filing’s statement that holdings are not intended to influence control is a standard disclosure but should be read alongside any future amendments or disclosures of coordination.

Armistice Capital, LLC e Steven Boyd dichiarano la titolarità beneficiaria di 2.675.610 azioni ordinarie di GeoVax Labs, pari al 9,54% della categoria. Armistice Capital è il gestore degli investimenti del detentore diretto (il Master Fund) e segnala di detenere poteri condivisi di voto e disposizione su queste azioni. Il Master Fund rinuncia a rivendicare la titolarità beneficiaria nella misura in cui non dispone di poteri di voto o dispositivi in base all’accordo con Armistice Capital.

La comunicazione precisa che le azioni sono detenute nell’ordinario corso dell’attività e non sono state acquisite al fine di modificare o influenzare il controllo dell’emittente. Steven Boyd, in qualità di managing member di Armistice Capital, è indicato come titolare degli stessi poteri condivisi di voto e disposizione.

Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria de 2.675.610 acciones ordinarias de GeoVax Labs, lo que representa el 9,54% de la clase. Armistice Capital es el gestor de inversiones del titular directo (el Master Fund) y declara tener poderes compartidos de voto y disposición sobre estas acciones. El Master Fund renuncia a la propiedad beneficiaria en la medida en que carezca de poderes de voto o disposición conforme a su acuerdo con Armistice Capital.

El documento indica que las acciones se mantienen en el curso ordinario del negocio y no se adquirieron con el objetivo de cambiar o influir en el control del emisor. Steven Boyd, como managing member de Armistice Capital, figura con los mismos poderes compartidos de voto y disposición.

Armistice Capital, LLC와 Steven Boyd는 GeoVax Labs 보통주 2,675,610주(해당 클래스의 9.54%)에 대한 실질적 소유권을 신고했습니다. Armistice Capital은 직접 보유자(마스터 펀드)의 투자 운용사로서 이 주식들에 대해 공동 의결권 및 처분권을 보유하고 있다고 보고했습니다. 마스터 펀드는 Armistice Capital과의 계약에 따라 의결권이나 처분권이 없는 범위에 대해서는 실질적 소유권을 부인합니다.

신고서에는 해당 주식이 영업상의 통상적인 범위에서 보유되고 있으며 발행사의 통제권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아니라고 명시되어 있습니다. Armistice Capital의 매니징 멤버인 Steven Boyd도 동일한 공동 의결권 및 처분권을 보유한 것으로 보고되었습니다.

Armistice Capital, LLC et Steven Boyd déclarent la propriété bénéficiaire de 2 675 610 actions ordinaires de GeoVax Labs, représentant 9,54 % de la catégorie. Armistice Capital est le gestionnaire d’investissements du détenteur direct (le Master Fund) et déclare exercer des pouvoirs partagés de vote et de disposition sur ces actions. Le Master Fund décline la qualité de bénéficiaire dans la mesure où il ne dispose pas de pouvoirs de vote ou de disposition en vertu de son accord avec Armistice Capital.

Le dépôt précise que les actions sont détenues dans le cours normal des affaires et n’ont pas été acquises dans le but de modifier ou d’influencer le contrôle de l’émetteur. Steven Boyd, en tant que managing member d’Armistice Capital, est indiqué comme disposant des mêmes pouvoirs partagés de vote et de disposition.

Armistice Capital, LLC und Steven Boyd melden wirtschaftliches Eigentum an 2.675.610 Stammaktien von GeoVax Labs, was 9,54% der Klasse entspricht. Armistice Capital ist der Investmentmanager des direkten Inhabers (des Master Fund) und gibt an, über diese Aktien geteilte Stimm- und Verfügungsrechte zu besitzen. Der Master Fund weist wirtschaftliches Eigentum in dem Umfang zurück, in dem ihm gemäß der Vereinbarung mit Armistice Capital Stimm- oder Verfügungsrechte fehlen.

Die Meldung führt aus, dass die Aktien im normalen Geschäftsverlauf gehalten werden und nicht erworben wurden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Steven Boyd wird als Managing Member von Armistice Capital mit denselben geteilten Stimm- und Verfügungsrechten angegeben.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:08/14/2025
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:08/14/2025
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: August 14, 2025 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd

FAQ

How many GeoVax Labs (GOVXW) shares do Armistice Capital and Steven Boyd report owning?

They report beneficial ownership of 2,675,610 shares, representing 9.54% of the class.

Do Armistice Capital or Steven Boyd have sole voting power over the reported shares?

No. The filing reports 0 shares with sole voting power and 2,675,610 shares with shared voting power.

Does the Master Fund claim beneficial ownership of the shares it holds?

The Master Fund specifically disclaims beneficial ownership of the securities to the extent it lacks voting or dispositive power due to its agreement with Armistice Capital.

Were the shares acquired to change or influence control of GeoVax Labs?

The filing certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What authority does Armistice Capital have over the shares?

Armistice Capital, as investment manager of the Master Fund, exercises the voting and investment power over the reported securities.
Geovax Labs Inc

NASDAQ:GOVXW

GOVXW Rankings

GOVXW Latest News

GOVXW Latest SEC Filings

GOVXW Stock Data

2.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
SMYRNA